HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
377.60
-1.38 (-0.36%)
Jul 8, 2025, 4:00 PM - Market closed
HCA Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 71,585 | 70,603 | 64,968 | 60,233 | 58,752 | 51,533 | Upgrade
| |
Revenue Growth (YoY) | 7.30% | 8.67% | 7.86% | 2.52% | 14.01% | 0.38% | Upgrade
|
Cost of Revenue | 42,308 | 41,925 | 39,389 | 37,056 | 36,260 | 32,243 | Upgrade
|
Gross Profit | 29,277 | 28,678 | 25,579 | 23,177 | 22,492 | 19,290 | Upgrade
|
Selling, General & Admin | 1,049 | 1,049 | 994 | 976 | 989 | 923 | Upgrade
|
Other Operating Expenses | 14,009 | 13,770 | 11,882 | 10,178 | 8,972 | 8,384 | Upgrade
|
Operating Expenses | 18,435 | 18,131 | 15,953 | 14,123 | 12,814 | 12,028 | Upgrade
|
Operating Income | 10,842 | 10,547 | 9,626 | 9,054 | 9,678 | 7,262 | Upgrade
|
Interest Expense | -2,096 | -2,061 | -1,938 | -1,741 | -1,566 | -1,584 | Upgrade
|
Earnings From Equity Investments | 43 | 23 | 22 | 45 | 113 | 54 | Upgrade
|
EBT Excluding Unusual Items | 8,789 | 8,509 | 7,710 | 7,358 | 8,225 | 5,732 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 1 | -1 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -186 | 14 | -5 | 1,301 | 1,620 | -7 | Upgrade
|
Other Unusual Items | - | - | - | -78 | -12 | -295 | Upgrade
|
Pretax Income | 8,603 | 8,523 | 7,706 | 8,580 | 9,833 | 5,430 | Upgrade
|
Income Tax Expense | 1,923 | 1,866 | 1,615 | 1,746 | 2,112 | 1,043 | Upgrade
|
Earnings From Continuing Operations | 6,680 | 6,657 | 6,091 | 6,834 | 7,721 | 4,387 | Upgrade
|
Minority Interest in Earnings | -901 | -897 | -849 | -1,191 | -765 | -633 | Upgrade
|
Net Income | 5,779 | 5,760 | 5,242 | 5,643 | 6,956 | 3,754 | Upgrade
|
Net Income to Common | 5,779 | 5,760 | 5,242 | 5,643 | 6,956 | 3,754 | Upgrade
|
Net Income Growth | 5.65% | 9.88% | -7.11% | -18.88% | 85.30% | 7.10% | Upgrade
|
Shares Outstanding (Basic) | 254 | 259 | 272 | 290 | 323 | 338 | Upgrade
|
Shares Outstanding (Diluted) | 257 | 262 | 276 | 295 | 329 | 344 | Upgrade
|
Shares Change (YoY) | -5.86% | -5.28% | -6.19% | -10.37% | -4.32% | -1.33% | Upgrade
|
EPS (Basic) | 22.73 | 22.27 | 19.24 | 19.44 | 21.51 | 11.10 | Upgrade
|
EPS (Diluted) | 22.47 | 22.00 | 18.97 | 19.15 | 21.16 | 10.93 | Upgrade
|
EPS Growth | 12.23% | 15.97% | -0.94% | -9.50% | 93.60% | 8.54% | Upgrade
|
Free Cash Flow | 4,948 | 5,639 | 4,687 | 4,127 | 5,382 | 6,397 | Upgrade
|
Free Cash Flow Per Share | 19.24 | 21.54 | 16.96 | 14.01 | 16.37 | 18.62 | Upgrade
|
Dividend Per Share | 2.700 | 2.640 | 2.400 | 2.240 | 1.920 | 0.430 | Upgrade
|
Dividend Growth | 9.76% | 10.00% | 7.14% | 16.67% | 346.51% | -73.13% | Upgrade
|
Gross Margin | 40.90% | 40.62% | 39.37% | 38.48% | 38.28% | 37.43% | Upgrade
|
Operating Margin | 15.15% | 14.94% | 14.82% | 15.03% | 16.47% | 14.09% | Upgrade
|
Profit Margin | 8.07% | 8.16% | 8.07% | 9.37% | 11.84% | 7.29% | Upgrade
|
Free Cash Flow Margin | 6.91% | 7.99% | 7.21% | 6.85% | 9.16% | 12.41% | Upgrade
|
EBITDA | 14,219 | 13,859 | 12,703 | 12,023 | 12,531 | 9,983 | Upgrade
|
EBITDA Margin | 19.86% | 19.63% | 19.55% | 19.96% | 21.33% | 19.37% | Upgrade
|
D&A For EBITDA | 3,377 | 3,312 | 3,077 | 2,969 | 2,853 | 2,721 | Upgrade
|
EBIT | 10,842 | 10,547 | 9,626 | 9,054 | 9,678 | 7,262 | Upgrade
|
EBIT Margin | 15.15% | 14.94% | 14.82% | 15.03% | 16.47% | 14.09% | Upgrade
|
Effective Tax Rate | 22.35% | 21.89% | 20.96% | 20.35% | 21.48% | 19.21% | Upgrade
|
Updated Apr 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.